12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Deals

arGEN-X, Eli Lilly deal

arGEN-X will generate mAb candidates against undisclosed targets from Eli Lilly. The pharma will have exclusive...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >